<div id="readability-page-1"><div><ul><li>Arteris Inc reported a quarterly adjusted loss of 9 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -8 cents. The mean expectation of four analysts for the quarter was for a loss of 9 cents per share. Wall Street expected results to range from -11 cents to -7 cents per share.</li><li>Revenue rose 18.3% to $17.41 million from a year ago; analysts expected $17.00 million. </li><li>Arteris Inc's reported EPS for the quarter was a loss of 21 cents​.</li><li>The company reported a quarterly loss of $8.99 million.</li><li>Arteris Inc shares had risen by 22.0% this quarter and gained 20.9% so far this year.</li></ul>FORECAST CHANGES<ul><li>The mean earnings estimate of analysts had fallen by about 2.8% in the last three months.​ </li><li>In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.</li></ul>RECOMMENDATIONS<ul><li>The current average analyst rating on the shares is &#34;buy&#34; and the breakdown of recommendations is 3 &#34;strong buy&#34; or &#34;buy,&#34; 1 &#34;hold&#34; and no &#34;sell&#34; or &#34;strong sell.&#34; The average consensus recommendation for the software peer group is also &#34;buy&#34; </li><li>Wall Street's median 12-month price target for Arteris Inc is $16.75, about 26.4% above its last closing price of $12.32</li></ul>This summary was machine generated from LSEG data November 5 at 06:21 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)<div><table><tbody><tr><td>QUARTER ENDING</td><td>ESTIMATE </td><td>ACTUAL</td><td>BEAT, MET, MISSED</td></tr><tr><td>Sep. 30 2025 </td><td>-0.09</td><td>-0.09</td><td>Met</td></tr><tr><td>Jun. 30 2025 </td><td>-0.10</td><td>-0.11</td><td>Missed</td></tr><tr><td>Mar. 31 2025 </td><td>-0.09</td><td>-0.09</td><td>Met</td></tr><tr><td>Dec. 31 2024 </td><td>-0.11</td><td>-0.10</td><td>Beat</td></tr></tbody></table></div></div></div>

Arteris Inc reported a quarterly adjusted loss of 9 cents per share for the quarter ended September 30, compared to a loss of 8 cents in the same quarter last year. Revenue increased by 18.3% to $17.41 million, exceeding analyst expectations of $17.00 million. The company reported a total loss of $8.99 million. Analysts maintain a "buy" rating on the stock, with a median 12-month price target of $16.75, representing a 26.4% upside from the last closing price of $12.32.

Arteris Inc reports results for the quarter ended September 30 - Earnings Summary